PSMB5 and neoplasm: Consequently, we distinguish between among the neutral-tumorigenic-specific inhibition of DNMT1/protein-x interaction and the tumor suppressor-like neutral-tumorigenic-specific inhibition of DNMT1/protein-x interaction (Figure 2C).